Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Rochester Medical Center, Rochester, United States.
Department of Cellular and Molecular Physiology, Yale University, New Haven, United States.
Elife. 2024 Jul 31;12:RP91540. doi: 10.7554/eLife.91540.
The kidneys facilitate energy conservation through reabsorption of nutrients including glucose. Almost all the filtered blood glucose is reabsorbed by the kidneys. Loss of glucose in urine (glycosuria) is offset by an increase in endogenous glucose production to maintain normal energy supply in the body. How the body senses this glucose loss and consequently enhances glucose production is unclear. Using renal (also known as ) knockout mice, we demonstrate that elevated glycosuria activates the hypothalamic-pituitary-adrenal axis, which in turn drives endogenous glucose production. This phenotype was attenuated by selective afferent renal denervation, indicating the involvement of the afferent nerves in promoting the compensatory increase in glucose production. In addition, through plasma proteomics analyses we observed that acute phase proteins - which are usually involved in the body's defense mechanisms against a threat - were the top candidates which were either upregulated or downregulated in renal KO mice. Overall, afferent renal nerves contribute to promoting endogenous glucose production in response to elevated glycosuria and loss of glucose in urine is sensed as a biological threat in mice. These findings may be useful in improving the efficiency of drugs like SGLT2 inhibitors that are intended to treat hyperglycemia by enhancing glycosuria but are met with a compensatory increase in endogenous glucose production.
肾脏通过重吸收包括葡萄糖在内的营养物质来促进能量节约。几乎所有滤过的血糖都被肾脏重吸收。尿中葡萄糖的丢失(糖尿)通过内源性葡萄糖生成的增加来抵消,以维持体内正常的能量供应。身体如何感知这种葡萄糖的丢失并因此增强葡萄糖的生成尚不清楚。使用肾脏(也称为)敲除小鼠,我们证明了升高的糖尿激活了下丘脑-垂体-肾上腺轴,进而驱动内源性葡萄糖生成。这种表型被选择性的传入肾神经切断术减弱,表明传入神经参与促进葡萄糖生成的代偿性增加。此外,通过血浆蛋白质组学分析,我们观察到急性期蛋白(通常参与机体对抗威胁的防御机制)是在肾脏 KO 小鼠中上调或下调的主要候选物。总的来说,传入肾神经有助于促进升高的糖尿时的内源性葡萄糖生成,而尿中葡萄糖的丢失被感知为小鼠中的生物威胁。这些发现可能有助于提高 SGLT2 抑制剂等药物的效率,这些药物旨在通过增强糖尿来治疗高血糖,但会遇到内源性葡萄糖生成的代偿性增加。